Members

Arizona    |    Florida    |   Minnesota    |    Co-Chairs

Arizona

Zoey Harris, M.D.

Zoey Harris, M.D., is a hematologist/oncologist and integrative oncologist at Mayo Clinic.

Dr. Harris’ clinical expertise spans both classical hematology and medical oncology, with a particular interest in immunohematology. Her practice includes the management of immune-mediated cytopenias, myeloproliferative neoplasms, bleeding and clotting disorders and complex diagnostic hematology. In her oncology work, she is dedicated to integrating evidence-based cancer therapies with supportive and holistic approaches that enhance quality of life and overall well-being for patients.

Dr. Harris is actively engaged in teaching and mentoring medical students, residents, and fellows in both inpatient and outpatient settings. She is passionate about medical education, with interests spanning from training future hematologists and oncologists to improving health literacy and shared decision-making for patients. She strives to provide compassionate, patient-centered care, partnering with patients in shared decision-making to align treatments with their health goals.

Dr. Yael N. Kusne, M.D., Ph.D.

Dr. Yael N. Kusne, M.D., Ph.D., is a board‑certified hematologist and an Assistant Professor of Medicine at the Mayo Clinic, where she specializes in pre‑myeloid and myeloid disorders. She treats conditions such as clonal hematopoiesis, clonal cytopenias, myelodysplastic syndromes, myeloproliferative neoplasms, chronic myeloid leukemia, and bone marrow failure.

Dr. Kusne earned her medical training at Mayo Clinic Arizona, where she completed her internal medicine residency and later her hematology/oncology fellowship. In research, her interests include the mechanisms and clinical implications of clonal hematopoiesis as well as germline mutations that predispose to hematologic malignancies.

Through her combined roles in patient care, teaching, and investigation, Dr. Kusne works at the intersection of cutting‑edge science and applied hematology. She is particularly focused on improving early detection, risk stratification, and management of blood disorders with a genetic or clonal component.

Leslie-J-Padrnos-MD

Leslie J. Padrnos, M.D.

Dr. Padrnos is a hematology–oncology specialist at Mayo Clinic, with a particular focus on nonmalignant hematology, thrombosis, and hemostasis. She practices in Phoenix, Arizona, where she is also affiliated with the Mayo Clinic hematology faculty.

Dr. Padrnos earned her medical degree from the University of Arizona in 2011. She completed her internal medicine residency and hematology/oncology fellowship at Mayo Clinic in Arizona, followed by an advanced fellowship as a Mayo Clinic Scholar in thrombosis and coagulopathy in collaboration with the University of Washington.

Clinically, Dr. Padrnos evaluates and manages complex thrombotic disorders, recurrent thrombosis, bleeding disorders, anticoagulation strategies, and chronic myeloid hematologic malignancies such as myeloproliferative neoplasms and myelodysplastic syndromes. She is also active in research and medical education, working to integrate patient‐centered care, education, and evidence‐based practice into her clinical work.

Dr. Padrnos holds board certifications in hematology and internal medicine/medical oncology, and over her career she has received recognition for her contributions to medical education, leadership within hematology, and scholarly work in coagulation and thrombosis.

Surbhi Shah MBBS

Surbhi Shah, M.B.B.S.

Dr.  Shah is a hematologist at Mayo Clinic in Phoenix, Arizona, where she cares for patients with non‑malignant blood disorders and complex clotting and bleeding conditions. Her clinical interests include immune hematology, thrombosis in high‑risk populations (such as individuals with cancer, antiphospholipid antibody syndrome etc) and hematological issues for patients with solid organ transplant .

She is deeply committed to patient‑centered care, practicing shared decision‑making and striving to integrate evidence into individualized care plans. In addition to her clinical work, Dr. Shah is active in education and mentorship, guiding medical students, residents, and fellows in hematology and oncology. Dr Shah is on several committees where she works with national and international experts in the field to create guidelines to help care for patients and define standard of care.

Dr. Shah also pursues systems based research that focuses on implementation and outcome, with a particular focus on thrombotic complications among high‑risk patient groups and the development of anticoagulation stewardship systems. She is part of the Kern Health Care Delivery Scholar Program at Mayo, where she works on building learning health systems around safe anticoagulation practices.

Her training included an M.B.B.S. degree from Jawaharlal Nehru Medical College, followed by residency in internal medicine and pathology, and fellowship in hematology, medical oncology, and transplantation. Dr. Shah has published on topics such as immunohematology, thrombosis, bleeding disorders, and interventions to improve care delivery in hematology.